Scigenic to export US$30 million worth of natural product

Published: 2002-04-30 06:56:00

Updated: 2002-04-30 06:56:00

Scigenic, a local bioventure firm, says that it signed with Celture Chem. of the US, a health food manufacturer, for its export of INM176, a health food ingredient for the prevention or treatment of dementia.

Under the agreement, Scigenic will supply to Celture Chem. a total of $30 million wo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK